| P2093 | author name string | Bin Liu | |
| | Ningning Wang | |
| | Xu Guo | |
| | Hongzhe Xie | |
| | Jiaming Huang | |
| | Jinfeng Tan | |
| | Liantang Wang | |
| | Lili Liang | |
| | Peiqi Ke | |
| | Xuejun Zhan | |
| | Yanxin Wu | |
| | Yongdong Liu | |
| P2860 | cites work | Endometrial angiogenesis throughout the human menstrual cycle | Q30693335 |
| | Adhesion of shed menstrual tissue in an in-vitro model using amnion and peritoneum: a light and electron microscopic study | Q57578235 |
| | Morphometric study of the stromal vascularization in peritoneal endometriosis | Q70624062 |
| | Association between endometriosis and polymorphisms in endostatin and vascular endothelial growth factor and their serum levels in Korean women | Q80272388 |
| | Effect of recombinant human endostatin on endometriosis in mice | Q80793833 |
| | Time course of pelvic endometriotic lesion revascularization in a nude mouse model | Q81016649 |
| | Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane | Q81481765 |
| | Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases | Q33677926 |
| | A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy | Q35088412 |
| | Intratumor microvessel density as a prognostic factor in cancer | Q35796301 |
| | Future perspectives in the medical treatment of endometriosis | Q36344314 |
| | Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro | Q38310536 |
| | Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity. | Q39796837 |
| | Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding | Q40935045 |
| | Quantitative assessment of human endometriotic tissue maintenance and regression in a noninvasive mouse model of endometriosis | Q44848772 |
| | Vascular endothelial growth factor (VEGF) in endometriosis | Q47750518 |
| | Antiangiogenesis therapy for endometriosis | Q47998790 |
| | Improved nude mouse models for green fluorescence human endometriosis. | Q50533235 |
| | Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. | Q51824074 |
| | Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. | Q51838090 |
| | Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane | Q57578219 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endometriosis | Q205764 |
| P304 | page(s) | 546479 | |
| P577 | publication date | 2014-06-24 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Antiangiogenesis therapy of endometriosis using PAMAM as a gene vector in a noninvasive animal model | |
| P478 | volume | 2014 | |